Navigation Links
Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
Date:4/7/2008

single-dose, randomised, double-blind, two-way crossover trial and used an active control. The trial involved 36 patients and was carried out by Prof. Bernd Jilma, MD, of the Medical University of Vienna (Department of Clinical Pharmacology).

The trial confirms data from the Indian market, where Neukine has been approved for therapy since 2004. Mani Iyer, Director IBPL, explains: "Over 3,000 cancer patients have already been treated with Neukine in India. No severe adverse reactions were reported, other than those commonly associated with Filgrastim. We are very confident that our joint clinical trials with Kwizda Pharma will demonstrate the quality of Neukine to the European authorities."

Logistics & Products

IBPL operates an EMEA-certified manufacturing facility in India since March 2007 and is now due to launch its products on the European market. As part of its business strategy, IBPL is working with Kwizda Pharma, which is helping to secure EU approval and will provide support with marketing logistics. Kwizda Pharma (established 1853), which has a well-established clinical background and extensive experience with regulatory procedures, is now offering its expertise to companies that manufacture biosimilar products, particularly those based in India.

Dr. Richard A Kwizda on the future prospects of this approach: "India has an excellent R&D basis and a skilled workforce, which makes its biosimilars attractive products for the European market. Our company supports Indian-based manufacturers of biosimilars to secure approval for the European market in a timely and cost-efficient manner."

About Kwizda GmbH

Kwizda GmbH is a privately owned group of companies and has been operating since 1853 (pharmaceutical division). Kwizda Pharma is a leading Austrian manufacturer and wholesaler of proprietary, in-licensed and third-party pharmaceuticals, OTC drugs and hospital infusions. In 2007, the company recorded sales of approximately
'/>"/>

SOURCE Kwizda Pharma GmbH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
2. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
3. Increasing Dairy Milk Production with Electrolyzed Drinking Water
4. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
5. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
6. ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line
7. On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
8. Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501
9. Data Demonstrate that Obagi Medical Products Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures
10. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
11. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 Research and Markets ( ... Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and ... Video communication has been the topic of fascination since ... United States and the Soviet Russia. Earlier even ...
(Date:1/23/2015)... analysis of Centers for Medicare and Medicaid Services, (CMS) ... percent of seniors chose lower-cost preferred pharmacy plans that ... The findings were released by Drug Channels . ... of Medicare Part D," said Pharmaceutical Care Management Association ...
(Date:1/23/2015)... and DUBLIN , Jan. 23, 2015 ... with KRS Global Biotechnology, Inc. for the compounding, packaging and ... for shipment in the United States . ... Outsourcing Facility capable of compounding naltrexone tablets in various strengths ...
Breaking Medicine Technology:Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4
... 31, 2011 Attorneys at Lewitt, Hackman, Shapiro, Marshall ... lawsuit regarding a Johnson & Johnson recall of DePuy ... the suit against DePuy Orthopedics, Inc. and its parent ... on behalf of a Los Angeles client. The lawsuit ...
... 31, 2011 Amarin Corporation plc (Nasdaq: AMRN ... disease, today issued a special letter to its shareholders. The ... Chairman and Chief Executive Officer of Amarin, follows: ... pleased to provide you with a brief review of Amarin,s ...
Cached Medicine Technology:Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit 2Amarin Provides 2010 Year-End Review to Shareholders 2Amarin Provides 2010 Year-End Review to Shareholders 3Amarin Provides 2010 Year-End Review to Shareholders 4Amarin Provides 2010 Year-End Review to Shareholders 5Amarin Provides 2010 Year-End Review to Shareholders 6Amarin Provides 2010 Year-End Review to Shareholders 7
(Date:1/22/2015)... A new white paper by The Beryl ... the long-term care environment as well as provides recommendations ... paper, “The Power of Person-Centeredness in Long-Term Care: A ... the patient, resident and family experience in long-term care ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the ... , Purchasing an accidental death and dismemberment rider for ... of rider provides benefits if the insured dies in an ... form of life insurance. , AD&D is not expensive ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne ... highest annual revenues in the past three years. Today, the ... dresses. , According to the sales manager of the company, ... them in 2015. This point can be reflected on the ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... Liverpool have found that the strength of uterine contractions in ... increasing the risk of emergency caesarean birth. ... by diabetes has increased by approximately 50%. There has, ... a quarter will have a normal vaginal delivery. ...
... body is undeniable. However, the idea of what makes a ... A new study from the Journal of Agriculture and ... determining the quality of a protein. Traditional methods for ... eggs to be high in quality. However, those who are interested ...
... of cells in the artery begins to regrow. In the ... Maria Gomez. A common cause of arterial injuries is ... have had a heart attack. "Initially the artery is ... the risk of further heart attacks." In animal experiments, ...
... increased by a record 5.9 per cent in 2010 ... Crisis (GFC), according to scientists working with the Global ... its annual analysis in the journal Nature Climate ... on emissions has been short-lived owing to strong emissions ...
... HealthDay Reporter , MONDAY, Dec. 5 (HealthDay News) -- A ... than his body weight, a novel finding that runs counter to ... the journal Circulation finds that improving or even just ... whether your body weight has stayed the same or even gone ...
... initiative improved employees, health behavior and well-being, including a rise ... management, according to a new study by University of Minnesota ... the December issue of the Journal of Health and ... from viewing time at the office as a sign of ...
Cached Medicine News:Health News:Poorly contracting uterus in diabetic women increases risk of caesarean birth 2Health News:Soy is on top as a high-quality plant protein 2Health News:Stopping dangerous cell regrowth reduces risk of further heart attacks 2Health News:Global Carbon Project annual emissions summary 2Health News:Fitness May Lower Death Risk Even Without Weight Loss 2Health News:Fitness May Lower Death Risk Even Without Weight Loss 3Health News:Study suggests flexible workplaces promote better health behavior and well-being 2
The combination of new measuring principle - Pupil Zone Imaging Method - and unique technology - SLD - offers high accuracy and reliability in refraction measurement....
... Module ACM-8 loads and unloads two centrifuges ... Identification via Cap Recognition the tube type ... in batches of three 5 position racks ... the single centrifuge ACM can be offered ...
... The Recapping System RCS 800 closes various plastic ... and easy way. Different tube heights and diameters ... tubes can be used for send-outs. The integration ... 800, Aliquoting System RSD 800 and High Throughput ...
... Nanogen offers reagents to detect ... human parainfluenza virus 1, 2 and ... and respiratory syncytial virus A and ... reagents to create homebrew tests., ...
Medicine Products: